Equities

VentriPoint Diagnostics Ltd

VentriPoint Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.195
  • Today's Change0.01 / 5.41%
  • Shares traded20.00k
  • 1 Year change-30.36%
  • Beta0.7959
Data delayed at least 15 minutes, as of Aug 14 2024 18:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Wednesday, VentriPoint Diagnostics Ltd (VPT:CVE) closed at 0.195, 44.44% above the 52 week low of 0.135 set on Nov 24, 2023.
52-week range
Today
0.135Nov 24 20230.36Jan 08 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.19
High0.195
Low0.19
Bid0.185
Offer0.195
Previous close0.185
Average volume40.38k
Shares outstanding157.18m
Free float153.79m
P/E (TTM)--
Market cap29.08m CAD
EPS (TTM)-0.0301
CAD
Data delayed at least 15 minutes, as of Aug 14 2024 18:55 BST.
More ▼

Events & Activity

  • VPT:CVE trading volume exceeds daily average by +117.98%
  • VPT:CVE price moved over +5.26% to 0.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.